CC
Casdin Capital Portfolio holdings
AUM $1.1B
1-Year Return
24.98%
This Quarter Return
+44.82%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$3.36B
AUM Growth
+$1.13B
(+50%)
Cap. Flow
+$516M
Cap. Flow
% of AUM
15.36%
Top 10 Holdings %
Top 10 Hldgs %
62.51%
Holding
56
New
11
Increased
11
Reduced
2
Closed
6
Top Buys
| 1 |
Exact Sciences
EXAS
|
+$197M |
| 2 |
NVTA
Invitae Corporation
NVTA
|
+$136M |
| 3 |
BioLife Solutions
BLFS
|
+$63.8M |
| 4 |
Beam Therapeutics
BEAM
|
+$37.6M |
| 5 |
4D Molecular Therapeutics
FDMT
|
+$32.4M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$119M |
| 2 |
AMRS
Amyris Inc.
AMRS
|
+$21.6M |
| 3 |
Illumina
ILMN
|
+$9.27M |
| 4 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
+$7.69M |
| 5 |
Legend Biotech
LEGN
|
+$4.31M |
Sector Composition
| 1 | Healthcare | 84.57% |
| 2 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Illumina
ILMN
$15.5B
| – | – |
-30,840
| Closed | -$9.27M |
|
|
52
Legend Biotech
LEGN
$6.25B
| – | – |
-139,661
| Closed | -$4.31M |
|
|
DCPH
53
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
-65,000
| Closed | -$3.34M |
|
|
ORTX
54
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| – | – |
-187,000
| Closed | -$7.69M |
|
|
AMRS
55
DELISTED
Amyris Inc.
AMRS
| – | – |
-7,390,000
| Closed | -$21.6M |
|
|
MYOK
56
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| – | – |
-870,000
| Closed | -$119M |
|